Search of: Canada - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 4975 studies with search of:

Canada

Hide studies that are not seeking new volunteers.

Display Options

1	Completed	Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
		Condition:	Multiple Sclerosis, Relapsing-Remitting
		Intervention:	Drug: Natalizumab

2	Completed	Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
		Condition:	Crohn's Disease
		Intervention:	Drug: Adalimumab

3	Completed	A New Oral Treatment For Type II Diabetes Mellitus
		Condition:	Non-Insulin-Dependent Diabetes Mellitus
		Intervention:	Drug: GW0823093

4	Completed	Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
		Condition:	Osteoarthritis of the Knee
		Intervention:	Drug: GW406381

5	Active, not recruiting	Prospective Evaluation of Proteinuria and Renal Function in Non-Diabetic Patients With Progressive Renal Disease
		Condition:	Hyperlipidemia
		Interventions:	Drug: Rosuvastatin; Drug: Atorvastatin

6	Completed	Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
		Conditions:	Dysmenorrhea; Dyspareunia; Endometriosis; Pelvic Pain
		Intervention:	Drug: ERB-041

7	Active, not recruiting	Safety Study of Apixaban in Recent Acute Coronary Syndrome
		Condition:	Acute Coronary Syndrome (ACS)
		Interventions:	Drug: Apixaban; Drug: Apixaban; Drug: Placebo

8	Active, not recruiting	Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
		Conditions:	Atrial Fibrillation; Cerebrovascular Accident
		Interventions:	Drug: Dabigatran etexilate; Drug: Warfarin

9	Recruiting	Temozolomide and Everolimus in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
		Condition:	Brain and Central Nervous System Tumors
		Interventions:	Drug: everolimus; Drug: temozolomide; Procedure: adjuvant therapy; Procedure: gene expression profiling; Procedure: immunohistochemistry staining method; Procedure: pharmacological study

10	Recruiting	A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin
		Conditions:	Non-Insulin-Dependent Diabetes Mellitus; Type 2 Diabetes
		Intervention:	Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET)

11	Recruiting	Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
		Condition:	Hepatitis C, Chronic
		Intervention:	Drug: Combination of pegylated interferon alfa-2b and ribavirin

12	Terminated	Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
		Condition:	Pulmonary Disease, Chronic Obstructive
		Interventions:	Drug: UK-432,097; Drug: Placebo

13	Recruiting	A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
		Condition:	Alzheimer's Disease
		Interventions:	Biological: PF-04360365; Drug: Placebo

14	Completed	Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.
		Conditions:	Pulmonary Disease, Chronic Obstructive; Asthma
		Intervention:	Drug: BI 1744CL

15	Active, not recruiting	Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
		Condition:	Pancreatic Cancer
		Interventions:	Drug: fluorouracil; Drug: gemcitabine hydrochloride; Drug: leucovorin calcium; Procedure: observation

16	Completed	Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
		Condition:	Gastroesophageal Reflux Disease (GERD)
		Intervention:	Drug: Esomeprazole

17	Completed	Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
		Condition:	Cardiovascular Diseases
		Interventions:	Drug: Telmisartan; Drug: Combination of Telmisartan and Ramipril; Drug: Ramipril

18	Completed	Chest Pain Pilot Study
		Conditions:	Chest Pain; Gastroesophageal Reflux
		Intervention:	Drug: Esomeprazole

19	Completed	Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
		Condition:	NSCLC
		Intervention:	Drug: Gefitinib

20	Active, not recruiting	The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes
		Condition:	Diabetes Mellitus, Type 2
		Interventions:	Drug: Lispro Mixture Therapy; Drug: Glargine Therapy; Drug: Glargine Basal-Bolus Therapy

21	Active, not recruiting	Combination Therapy for Age-Related Macular Degeneration.
		Condition:	Age Related Macular Degeneration
		Interventions:	Drug: Avastin (Bevacizumab); Drug: Bevacizumab; Drug: Bevacizumab; Drug: Bevacizumab

22	Active, not recruiting	A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety
		Condition:	Obesity
		Interventions:	Drug: CP-945,598 Treatment A; Drug: Placebo; Drug: CP-945,598 Treatment B

23	Recruiting	Assessment and Tracking of Long-Term Alefacept Safety
		Condition:	Psoriasis
		Intervention:	Drug: Alefacept exposure

24	Recruiting	A Canadian Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
		Condition:	Schizophrenia
		Intervention:	Drug: Quetiapine Fumarate Extended- Release

25	Recruiting	LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
		Conditions:	ErbB2 (HER2) Amplified Gastric; Esophageal; or Gastro-Esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
		Intervention:	Drug: Lapatinib

26	Recruiting	Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
		Condition:	Venous Thrombosis
		Interventions:	Drug: Enoxaparin; Drug: warfarin; Drug: Placebo for apixaban; Drug: Placebo for enoxaparin; Drug: Placebo for warfarin; Drug: apixaban

27	Completed	Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
		Condition:	Rotavirus Gastroenteritis
		Interventions:	Biological: Human Rotavirus Vaccine - two different formulations; Biological: Prevnar; Biological: IPOL; Biological: Infanrix; Biological: OmniHIB; Biological: Pentacel; Biological: Placebo

28	Completed	Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-Small Cell Lung Cancer
		Condition:	Lung Cancer
		Interventions:	Drug: carboplatin; Drug: efaproxiral; Drug: paclitaxel; Procedure: chemotherapy; Procedure: radiation therapy

29	Active, not recruiting	Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
		Condition:	Prostate Cancer
		Intervention:	Procedure: radiation therapy

30	Completed	Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
		Conditions:	Brain and Central Nervous System Tumors; Lymphoma; Neuroblastoma; Retinoblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
		Intervention:	Drug: becatecarin

31	Completed	Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
		Condition:	Leukemia
		Interventions:	Drug: asparaginase; Drug: cyclophosphamide; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: doxorubicin hydrochloride; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: nelarabine; Drug: pegaspargase; Drug: prednisone; Drug: thioguanine; Drug: vincristine sulfate; Procedure: radiation therapy

32	Active, not recruiting	Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
		Condition:	Breast Cancer
		Interventions:	Drug: capecitabine; Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: fluorouracil; Drug: methotrexate; Procedure: adjuvant therapy

33	Active, not recruiting	Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
		Condition:	Brain and Central Nervous System Tumors
		Interventions:	Drug: lomustine; Drug: temozolomide; Procedure: adjuvant therapy; Procedure: radiation therapy

34	Recruiting	Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
		Conditions:	Osteoarthritis; Arthritis, Rheumatoid
		Interventions:	Drug: Celecoxib; Drug: Diclofenac + Omeprazole

35	Completed	To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
		Condition:	Alzheimer's Disease
		Intervention:	Drug: Atorvastatin

36	Completed	Comparative Atorvastatin Pleiotropic Effects
		Conditions:	Coronary Arteriosclerosis; Hypercholesterolemia
		Interventions:	Procedure: Blood samples; Drug: Atorvastatin

37	Completed	Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
		Condition:	Osteoporosis
		Intervention:	Drug: teriparatide

38	Recruiting	Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
		Conditions:	Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive
		Interventions:	Drug: Aldosterone Antagonist (spironolactone); Drug: Placebo

39	Completed	Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
		Conditions:	Schizophrenia; Schizoaffective Disorder; Bipolar Disorder
		Interventions:	Drug: dissolvable olanzapine under the tongue; Drug: olanzapine pills swallowed; Drug: placebo

40	Recruiting	PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
		Condition:	Non Hodgkin Lymphoma
		Interventions:	Drug: enzastaurin; Drug: placebo

41	Active, not recruiting	Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
		Conditions:	Breast Cancer; Osteoporosis
		Interventions:	Drug: alendronate sodium; Drug: calcium carbonate; Drug: calcium citrate; Drug: calcium gluconate; Drug: cholecalciferol; Drug: risedronate sodium; Procedure: dual x-ray absorptometry; Procedure: laboratory biomarker analysis

42	Recruiting	A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.
		Condition:	Anemia
		Interventions:	Drug: methoxy polyethylene glycol-epoetin beta [Mircera]; Drug: Darbepoetin alfa

43	Recruiting	Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness
		Conditions:	Venous Thrombosis; Pulmonary Embolism
		Interventions:	Drug: Apixaban; Drug: Enoxaparin

44	Terminated	Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
		Condition:	Acute Ischemic Stroke
		Intervention:	Drug: alfimeprase

45	Enrolling by invitation	Open Label Continuation Study in Moderate to Severe Psoriasis
		Condition:	Moderate to Severe Plaque Psoriasis
		Intervention:	Drug: ABT-874

46	Recruiting	Phase IIIB Switching From Intravenous to Subcutaneous Study
		Condition:	Arthritis, Rheumatoid
		Intervention:	Drug: Abatacept

47	Completed	Cognition in the Study of Tamoxifen and Raloxifene
		Conditions:	Cognition; Aging
		Interventions:	Drug: tamoxifen; Drug: raloxifene

48	Completed	Study of ZARNESTRA™ as Postconsolidation Therapy for Acute Myeloid Leukemia in Subjects 60 Years & Older
		Condition:	Acute Myeloid Leukemia
		Intervention:	Drug: ZARNESTRA

49	Completed	Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
		Condition:	Narcolepsy
		Intervention:	Drug: sodium oxybate

50	Completed	SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
		Condition:	Pulmonary Embolism
		Interventions:	Drug: SR34006; Drug: (LMW)heparin; Drug: Warfarin VKA; Drug: Acenocoumarol VKA

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options